Who Just RaisedSeattle, WA · Health Care · Form D filed Aug 14, 2026
Strella Biotechnology, Inc. raised $1.8M
Strella Biotechnology, Inc. is a biotechnology company based in Seattle, Washington. In a Form D filed with the SEC on August 14, 2026, it reported raising $1,761,591 from 35 investors as part of an offering of up to $3,250,000. The first sale in the offering took place on June 29, 2026.
- 3rd Form D since 2020. Earlier new notices: Sep 10, 2024 · Apr 17, 2020. All filings on EDGAR
- Still raising. $1.5M of the $3.3M offering was still unsold at filing.
$10.7M raised since 2020
3 Form D offerings, as reported to the SEC, the first in Apr 17, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 14, 2026 | $1.8M | $3.3M | 35 |
| Sep 10, 2024 | $5.6M | $5.6M | 17 |
| Apr 17, 2020 | $3.3M | $3.3M | 17 |
Lead score
26 out of 100
early raise still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $1,761,591
- Offering size
- $3,250,000
- Investors so far
- 35
- First sale
- June 29, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Seattle, Washington
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,761,591 | $3,250,000 | 35 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 10, 2026 · Health Care funding in Washington · August 2026 funding report
Similar raises
Life Stylistic, Inc.
Seattle, WA · filed Oct 15
Cultural commerce solutions.
First Form DStill raising
LevelTen Energy, Inc.
Seattle, WA · filed Oct 810th Form D since 2017
CytoTerra Inc.
Seattle, WA · filed Oct 72nd Form D since 2026Still raising
Q-Immune, Inc.
Seattle, WA · filed Sep 28
CAR-T can cure. Q-Immune makes it safe, with a lab that teaches AI how engineered cells behave.
First Form DStill raising
Seattle Neurosound Solutions, Inc.
Seattle, WA · filed Sep 22First Form DStill raising
Hexamer Therapeutics, Inc
Pullman, WA · filed Sep 153rd Form D since 2019Still raising
DexCare, Inc.
Seattle, WA · filed Sep 143rd Form D since 2021Still raising
Aptevo Therapeutics Inc.
Seattle, WA · filed Aug 26
2nd Form D since 2025